HRTX

Heron Therapeutics, Inc.

1.33

USD

HRTX Earnings Reports

Positive Surprise Ratio

HRTX beat 20 of 39 last estimates.

51%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$40.62M

-$0.02

Implied change from Q3 25 (Revenue/ EPS)

+6.30%

-50.00%

Implied change from Q4 24 (Revenue/ EPS)

-0.39%

-200.00%

Heron Therapeutics, Inc. earnings per share and revenue

On Nov 04, 2025, HRTX reported earnings of -0.04 USD per share (EPS) for Q3 25, missing the estimate of -0.01 USD, resulting in a -161.44% surprise. Revenue reached 38.21 million, compared to an expected 39.81 million, with a -4.02% difference. The market reacted with a -3.39% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 40.62 million USD, implying an decrease of -50.00% EPS, and increase of 6.30% in Revenue from the last quarter.

FAQ

What were Heron Therapeutics, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Heron Therapeutics, Inc. reported EPS of -$0.04, missing estimates by -161.44%, and revenue of $38.21M, -4.02% below expectations.

How did the market react to Heron Therapeutics, Inc.'s Q3 2025 earnings?

The stock price moved down -3.39%, changed from $1.18 before the earnings release to $1.14 the day after.

When is Heron Therapeutics, Inc. expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Heron Therapeutics, Inc.'s next earnings report?

Based on 6 analysts, Heron Therapeutics, Inc. is expected to report EPS of -$0.02 and revenue of $40.62M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.